216 related articles for article (PubMed ID: 26395924)
1. Sustained-release steroids for the treatment of diabetic macular edema.
Daruich A; Matet A; Behar-Cohen F
Curr Diab Rep; 2015 Nov; 15(11):99. PubMed ID: 26395924
[TBL] [Abstract][Full Text] [Related]
2. Steroids and macular edema from retinal vein occlusion.
Glacet-Bernard A; Coscas G; Zourdani A; Soubrane G; Souied EH
Eur J Ophthalmol; 2011; 21 Suppl 6():S37-44. PubMed ID: 23264327
[TBL] [Abstract][Full Text] [Related]
3. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.
Ciulla TA; Harris A; McIntyre N; Jonescu-Cuypers C
Expert Opin Pharmacother; 2014 May; 15(7):953-9. PubMed ID: 24661081
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation.
Sadiq MA; Agarwal A; Soliman MK; Hanout M; Sarwar S; Do DV; Nguyen QD
Expert Opin Drug Saf; 2015 Jul; 14(7):1147-56. PubMed ID: 25994877
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Steroids in Diabetic Macular Edema.
Lattanzio R; Cicinelli MV; Bandello F
Dev Ophthalmol; 2017; 60():78-90. PubMed ID: 28427068
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal inserts of steroids to treat diabetic macular edema.
Montero JA; Ruiz-Moreno JM
Curr Diabetes Rev; 2009 Feb; 5(1):26-32. PubMed ID: 19199895
[TBL] [Abstract][Full Text] [Related]
7. An updated review of long-term outcomes from randomized controlled trials in approved pharmaceuticals for diabetic macular edema.
Wang JK; Huang TL; Su PY; Chang PY
Eye Sci; 2015 Dec; 30(4):176-83. PubMed ID: 27215008
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal steroids for macular edema: the past, the present, and the future.
Cunningham MA; Edelman JL; Kaushal S
Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
[TBL] [Abstract][Full Text] [Related]
9. Fluocinolone acetonide for the treatment of diabetic macular edema.
Haritoglou C; Mayer W; Wolf A
Expert Rev Clin Pharmacol; 2016; 9(3):367-74. PubMed ID: 26681198
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal steroids in the management of macular oedema.
Sivaprasad S; McCluskey P; Lightman S
Acta Ophthalmol Scand; 2006 Dec; 84(6):722-33. PubMed ID: 17083528
[TBL] [Abstract][Full Text] [Related]
11. Update on treatments for diabetic macular edema.
Fraser-Bell S; Kaines A; Hykin PG
Curr Opin Ophthalmol; 2008 May; 19(3):185-9. PubMed ID: 18408491
[TBL] [Abstract][Full Text] [Related]
12. [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].
Soubrane G; Behar-Cohen F
J Fr Ophtalmol; 2015 Feb; 38(2):159-67. PubMed ID: 25601517
[TBL] [Abstract][Full Text] [Related]
13. Fluocinolone acetonide for the treatment of diabetic macular edema.
Veritti D; Sarao V; Diplotti L; Samassa F; Lanzetta P
Expert Opin Pharmacother; 2017 Oct; 18(14):1507-1516. PubMed ID: 28764565
[TBL] [Abstract][Full Text] [Related]
14. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
[TBL] [Abstract][Full Text] [Related]
15. The role of steroids in the management of uveitic macular edema.
de Smet MD; Julian K
Eur J Ophthalmol; 2011; 21 Suppl 6():S51-5. PubMed ID: 23264329
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema.
Cardillo JA; Souza-Filho AA; Oliveira AG
Arch Soc Esp Oftalmol; 2006 Dec; 81(12):675-7, 679-81. PubMed ID: 17199160
[No Abstract] [Full Text] [Related]
17. Update of intravitreal steroids for the treatment of diabetic macular edema.
Bandello F; Preziosa C; Querques G; Lattanzio R
Ophthalmic Res; 2014; 52(2):89-96. PubMed ID: 25195600
[TBL] [Abstract][Full Text] [Related]
18. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
Daull P; Paterson CA; Kuppermann BD; Garrigue JS
J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.
Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C
Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851
[TBL] [Abstract][Full Text] [Related]
20. Widening use of dexamethasone implant for the treatment of macular edema.
Bonfiglio V; Reibaldi M; Fallico M; Russo A; Pizzo A; Fichera S; Rapisarda C; Macchi I; Avitabile T; Longo A
Drug Des Devel Ther; 2017; 11():2359-2372. PubMed ID: 28860707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
